Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea
· Delayed Price · Currency is KRW 9,040.00
-70.00 (-0.77%)
At close: Mar 21, 2025, 3:30 PM KST
KOSDAQ:036480 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -1,769 | -679.68 | 1,703 | 865.92 | 1,519 | Upgrade
|
| Depreciation & Amortization | 1,715 | 2,862 | 2,706 | 2,538 | 1,948 | Upgrade
|
| Loss (Gain) From Sale of Assets | -16.26 | 0.07 | -2,219 | -7 | -11.72 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 274.54 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.19 | 0.29 | 0.91 | 0.3 | 0.12 | Upgrade
|
| Loss (Gain) on Equity Investments | 27.7 | -36.39 | 14.6 | 4.97 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 170.82 | 27.09 | 29.42 | 12.07 | 116.72 | Upgrade
|
| Other Operating Activities | 887.1 | -342.66 | 881.17 | 367.84 | 939.73 | Upgrade
|
| Change in Accounts Receivable | 229.73 | -1,130 | -103.07 | 516.13 | -809.4 | Upgrade
|
| Change in Inventory | 1,536 | -1,132 | -1,027 | -1,417 | 69.22 | Upgrade
|
| Change in Accounts Payable | -226.87 | 565.26 | 209.1 | -468.3 | -575.83 | Upgrade
|
| Change in Other Net Operating Assets | -450.67 | -1,368 | -1,039 | -209.63 | -233.28 | Upgrade
|
| Operating Cash Flow | 2,103 | -1,234 | 1,155 | 2,203 | 3,236 | Upgrade
|
| Operating Cash Flow Growth | - | - | -47.56% | -31.92% | 39.77% | Upgrade
|
| Capital Expenditures | -795.32 | -1,256 | -2,315 | -2,968 | -14,006 | Upgrade
|
| Sale of Property, Plant & Equipment | 18.64 | 59.09 | 4,572 | 7 | 24.09 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.55 | -3.96 | -0.39 | -0.8 | -437.9 | Upgrade
|
| Investment in Securities | 2,197 | 1,437 | -3,415 | -678.96 | -1,152 | Upgrade
|
| Other Investing Activities | - | - | 0 | 0 | -0 | Upgrade
|
| Investing Cash Flow | 1,419 | 235.73 | -1,158 | -3,641 | -15,572 | Upgrade
|
| Short-Term Debt Issued | 1,000 | 3,319 | 2,000 | 700 | 700 | Upgrade
|
| Long-Term Debt Issued | 15,500 | 3,000 | - | 800 | 10,050 | Upgrade
|
| Total Debt Issued | 16,500 | 6,319 | 2,000 | 1,500 | 10,750 | Upgrade
|
| Short-Term Debt Repaid | -5,319 | - | -700 | -700 | -700 | Upgrade
|
| Long-Term Debt Repaid | -15,374 | -4,553 | -1,661 | -172.18 | -168.81 | Upgrade
|
| Total Debt Repaid | -20,692 | -4,553 | -2,361 | -872.18 | -868.81 | Upgrade
|
| Net Debt Issued (Repaid) | -4,192 | 1,766 | -361.29 | 627.82 | 9,881 | Upgrade
|
| Dividends Paid | -285 | -285 | -285 | -323 | -323 | Upgrade
|
| Other Financing Activities | - | - | - | -0 | - | Upgrade
|
| Financing Cash Flow | -4,477 | 1,481 | -646.29 | 304.82 | 9,558 | Upgrade
|
| Foreign Exchange Rate Adjustments | 222.84 | 28.2 | 105.91 | 316.07 | -262.8 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | 0 | 0 | Upgrade
|
| Net Cash Flow | -731.96 | 510.68 | -543.44 | -816.59 | -3,040 | Upgrade
|
| Free Cash Flow | 1,308 | -2,490 | -1,160 | -764.71 | -10,770 | Upgrade
|
| Free Cash Flow Margin | 5.49% | -9.74% | -4.55% | -3.19% | -43.43% | Upgrade
|
| Free Cash Flow Per Share | 344.42 | -655.75 | -305.03 | -200.47 | -2836.73 | Upgrade
|
| Cash Interest Paid | 909.4 | 955.25 | 458.48 | 271.46 | 2.85 | Upgrade
|
| Cash Income Tax Paid | -52.12 | 475.4 | 46.03 | -94.73 | 187.82 | Upgrade
|
| Levered Free Cash Flow | 1,543 | -1,862 | -997.53 | -1,065 | -12,016 | Upgrade
|
| Unlevered Free Cash Flow | 2,072 | -1,304 | -677.16 | -891.44 | -12,009 | Upgrade
|
| Change in Net Working Capital | -2,122 | 2,476 | 862.75 | 671.53 | 711.13 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.